H18.04 Kayser-Fleischer ring

Name of the Condition

• Kayser-Fleischer Ring
• ICD Code: H18.04

Summary

Kayser-Fleischer ring is a brownish or greenish ring of copper deposition in the cornea, typically located at the limbus (the border between the cornea and sclera). This finding is a key clinical sign of Wilson disease, a genetic disorder affecting copper metabolism. The ring may be visible to the naked eye in advanced cases but is often detected via slit-lamp examination.

Causes

Kayser-Fleischer ring results from abnormal copper accumulation in the body due to impaired biliary excretion, a hallmark of Wilson disease. Copper deposits in the Descemet membrane of the cornea, forming the characteristic ring. The underlying cause is mutations in the ATP7B gene, which disrupts copper transport and elimination.

Risk Factors

• Genetic predisposition (family history of Wilson disease)
• Age (typically appears in late childhood or early adulthood)
• Untreated or poorly managed Wilson disease
• Lack of copper metabolism screening in at-risk individuals

Symptoms

• Often asymptomatic initially; may be detected during routine eye exams
• In advanced cases, potential visual disturbances (e.g., glare, blurred vision)
• Associated systemic symptoms of Wilson disease (e.g., liver dysfunction, neurological issues)

Diagnosis

Diagnosis involves slit-lamp examination to visualize the corneal ring, often confirming with copper studies (e.g., serum ceruloplasmin, 24-hour urinary copper) and genetic testing for ATP7B mutations. Liver function tests and imaging may also be performed to assess systemic involvement.

Treatment Options

Treatment focuses on reducing copper levels, typically with chelating agents (e.g., penicillamine, trientine) or zinc supplements. Regular monitoring of copper levels and liver function is essential. For severe cases, liver transplantation may be considered.

Prognosis and Follow-Up

With early diagnosis and treatment, prognosis is favorable, and the Kayser-Fleischer ring may regress. Untreated Wilson disease can lead to progressive liver damage, neurological decline, or death. Lifelong monitoring and adherence to therapy are critical.

Complications

• Progressive liver cirrhosis or failure
• Neurological deterioration (e.g., tremors, cognitive changes)
• Hemolytic anemia (rare)
• Renal or cardiac involvement in advanced disease

Lifestyle & Prevention

• Genetic counseling for affected families
• Avoidance of copper-rich foods (e.g., shellfish, organ meats) in diagnosed cases
• Regular medical follow-up to monitor copper levels and organ function
• Adherence to prescribed chelation therapy or supplements

When to Seek Professional Help

Seek immediate medical attention if experiencing unexplained liver or neurological symptoms, or if a corneal ring is detected during an eye exam. Early intervention is vital to prevent irreversible organ damage.

Tips for Medical Coders

Document the presence of Kayser-Fleischer ring with clinical confirmation (e.g., slit-lamp findings) and note any associated Wilson disease diagnosis. Ensure coding aligns with the ICD-10-CM guidelines for H18.04, specifying the ring as a distinct corneal finding. Include relevant clinical details to support the diagnosis in the medical record.